Page last updated: 2024-10-23

bisoprolol and Centriacinar Emphysema

bisoprolol has been researched along with Centriacinar Emphysema in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
"Emphysema was induced in male Wistar rats by four weekly pulmonary instillations of elastase (4UI) and exacerbation by a single dose of lipopolysaccharides (LPS)."1.91Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema. ( Alburquerque, L; Bideaux, P; Bourdin, A; Cazorla, O; Charrabi, A; Desplanche, E; Gouzi, F; Grillet, PE; Virsolvy, A; Wynands, Q, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Desplanche, E1
Grillet, PE1
Wynands, Q1
Bideaux, P1
Alburquerque, L1
Charrabi, A1
Bourdin, A1
Cazorla, O1
Gouzi, F1
Virsolvy, A1

Other Studies

1 other study available for bisoprolol and Centriacinar Emphysema

ArticleYear
Elevated Blood Pressure Occurs without Endothelial Dysfunction in a Rat Model of Pulmonary Emphysema.
    International journal of molecular sciences, 2023, Aug-09, Volume: 24, Issue:16

    Topics: Animals; Bisoprolol; Blood Pressure; Emphysema; Heart Failure; Hypertension; Male; Pulmonary Disease

2023